aTYR PHARMA (ATYR) Equity Ratio (2019 - 2025)
aTYR PHARMA's Equity Ratio history spans 7 years, with the latest figure at 0.73 for Q4 2025.
- For Q4 2025, Equity Ratio changed 0.34% year-over-year to 0.73; the TTM value through Dec 2025 reached 0.73, changed 0.34%, while the annual FY2025 figure was 0.73, 0.34% changed from the prior year.
- Equity Ratio reached 0.73 in Q4 2025 per ATYR's latest filing, down from 0.75 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.95 in Q3 2021 to a low of 0.71 in Q3 2024.
- Average Equity Ratio over 5 years is 0.8, with a median of 0.78 recorded in 2023.
- Peak YoY movement for Equity Ratio: increased 23.32% in 2021, then decreased 21.21% in 2022.
- A 5-year view of Equity Ratio shows it stood at 0.94 in 2021, then fell by 21.21% to 0.74 in 2022, then increased by 0.76% to 0.75 in 2023, then dropped by 3.56% to 0.72 in 2024, then grew by 0.34% to 0.73 in 2025.
- Per Business Quant, the three most recent readings for ATYR's Equity Ratio are 0.73 (Q4 2025), 0.75 (Q3 2025), and 0.74 (Q2 2025).